IP Library › Granted Patent US 10,918,744
Granted Patent B2
US 10,918,744 · App. 16/489,607 · Granted Feb 16, 2021

Biometric method

Inventors: Kazuhiro Ichikawa (Nagasaki, JP); Tatsuya Naganuma (Fukuoka, JP)
Assignees: Educational foundation Kyushu Bunka Gakuen; JAPAN REDOX LIMITED
A61K49/20A61B5/055G01R33/483G01R33/60
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,918,744
App. No.
16/489,607
Granted
Feb 16, 2021
Kind
B2
Abstract

A biometric method includes: a step ( 1 ) for administering, to a target organism from the outside thereof, one of (i) a target molecule A having both an unpaired electron and a magnetic resonance nucleus having a gyromagnetic ratio smaller than the same of 19 F, and (ii) a target molecule B and a radical molecule C, the target molecule B having no unpaired electron, and further having a magnetic resonance nucleus having a gyromagnetic ratio smaller than the same of 19 F, the radical molecule C having an unpaired electron; and a step ( 2 ) for causing electron spin resonance in the unpaired electron of the target molecule A or the radical molecule C by irradiating electromagnetic waves to the target organism, subsequently triggering nuclear magnetic resonance in the magnetic resonance nucleus having a gyromagnetic ratio smaller than the same of 19 F in one of the target molecule A and the target molecule B, and further, measuring nuclear magnetic resonance signals. The step ( 2 ) is carried out in a magnetic field having such an intensity that the nuclear magnetic resonance signals of the magnetic resonance nucleus in one of the target molecule A and the target molecule B are degenerated, the magnetic resonance nucleus having a gyromagnetic ratio smaller than the same of 19 F. The biometric method makes it possible to measure low-sensitivity magnetic resonance nucleus such as 13 C, 15 N, and 31 P, which are important nuclides present in organism, with performance equal to or over that of a high-field MRI device.

Claims (26)

1. A biometric method including:

a step (1) for administering, to a target organism from the outside thereof, one of (i) a target molecule A having both an unpaired electron and a magnetic resonance nucleus having a gyromagnetic ratio smaller than the same of 19 F, and (ii) a target molecule B and a radical molecule C, the target molecule B having no unpaired electron, and further having a magnetic resonance nucleus having a gyromagnetic ratio smaller than the same of 19 F, the radical molecule C having an unpaired electron; and

a step (2) for causing electron spin resonance in the unpaired electron of the target molecule A or the radical molecule C by irradiating electromagnetic waves to the target organism, subsequently triggering nuclear magnetic resonance in the magnetic resonance nucleus having a gyromagnetic ratio smaller than the same of 19 F in one of the target molecule A and the target molecule B, and further, measuring nuclear magnetic resonance signals,

the step (2) being carried out in a magnetic field having such an intensity that the nuclear magnetic resonance signals of the magnetic resonance nucleus in one of the target molecule A and the target molecule B are degenerated, the magnetic resonance nucleus having a gyromagnetic ratio smaller than the same of 19 F.

2. The biometric method as set forth in claim 1 , wherein the magnetic resonance nucleus comprises one of 13 C, 14 N, 15 N, and 31 P.

3. The biometric method as set forth in claim 1 , wherein the step (2) is carried out in a magnetic field having an intensity equal to or smaller than 50 mT.

4. The biometric method as set forth in claim 1 , wherein the step (2) is carried out in a magnetic field having a constant intensity.

5. The biometric method as set forth in claim 1 , wherein one of the target molecule A and the target molecule B includes two or more magnetic resonance nuclei having a gyromagnetic ratio smaller than the same of 19 F.

6. The biometric method as set forth in claim 1 , wherein one of the target molecule A and the target molecule B has accumulation characteristics to tumor.

7. The biometric method as set forth in claim 1 , wherein one of the target molecule A and the target molecule B comprises glucose derivative.

8. A biometric apparatus including:

a first device for administering, to a target organism from the outside thereof, one of (i) a target molecule A having both an unpaired electron and a magnetic resonance nucleus having a gyromagnetic ratio smaller than the same of 19 F, and (ii) a target molecule B and a radical molecule C, the target molecule B having no unpaired electron, and further having a magnetic resonance nucleus having a gyromagnetic ratio smaller than the same of 19 F, the radical molecule C having an unpaired electron; and

a second device for causing electron spin resonance in the unpaired electron of the target molecule A or the radical molecule C by irradiating electromagnetic waves to the target organism, subsequently triggering nuclear magnetic resonance in the magnetic resonance nucleus having a gyromagnetic ratio smaller than the same of 19 F in one of the target molecule A and the target molecule B, and further, measuring nuclear magnetic resonance signals,

the second device measuring the nuclear magnetic resonance signals in a magnetic field having such an intensity that the nuclear magnetic resonance signals of the magnetic resonance nucleus in one of the target molecule A and the target molecule B are degenerated, the magnetic resonance nucleus having a gyromagnetic ratio smaller than the same of 19 F.

9. The biometric apparatus as set forth in claim 8 , wherein the magnetic resonance nucleus comprises one of 13 C, 14 N, 15 N, and 31 P.

10. The biometric apparatus as set forth in claim 8 , wherein the second device measures the nuclear magnetic resonance signals in a magnetic field having an intensity equal to or smaller than 50 mT.

11. The biometric apparatus as set forth in claim 8 , wherein the second device measures the nuclear magnetic resonance signals in a magnetic field having a constant intensity.

12. The biometric apparatus as set forth in claim 8 , wherein one of the target molecule A and the target molecule B includes two or more magnetic resonance nuclei having a gyromagnetic ratio smaller than the same of 19 F.

13. The biometric apparatus as set forth in claim 8 , wherein one of the target molecule A and the target molecule B has accumulation characteristics to tumor.

14. The biometric apparatus as set forth in claim 8 , wherein one of the target molecule A and the target molecule B comprises glucose derivative.

15. A non-transitory recording medium readable by a computer, storing a program therein for causing a computer to carry out a biometric method in a biometric apparatus, the method including:

a step (1) for administering, to a target organism from the outside thereof, one of (i) a target molecule A having both an unpaired electron and a magnetic resonance nucleus having a gyromagnetic ratio smaller than the same of 19 F, and (ii) a target molecule B and a radical molecule C, the target molecule B having no unpaired electron, and further having a magnetic resonance nucleus having a gyromagnetic ratio smaller than the same of 19 F, the radical molecule C having an unpaired electron; and

a step (2) for causing electron spin resonance in the unpaired electron of the target molecule A or the radical molecule C by irradiating electromagnetic waves to the target organism, subsequently triggering nuclear magnetic resonance in the magnetic resonance nucleus having a gyromagnetic ratio smaller than the same of 19 F in one of the target molecule A and the target molecule B, and further, measuring nuclear magnetic resonance signals,

the step (2) being carried out in a magnetic field having such an intensity that the nuclear magnetic resonance signals of the magnetic resonance nucleus in one of the target molecule A and the target molecule B are degenerated, the magnetic resonance nucleus having a gyromagnetic ratio smaller than the same of 19 F.

16. The non-transitory recording medium as set forth in claim 15 , wherein the step (2) is carried out in a magnetic field having an intensity equal to or smaller than 50 mT.

17. The non-transitory recording medium as set forth in claim 15 , wherein the step (2) is carried out in a magnetic field having a constant intensity.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2019
From: ICHIKAWA, KAZUHIRO; NAGANUMA, TATSUYA
To: EDUCATIONAL FOUNDATION KYUSHU BUNKA GAKUEN; JAPAN REDOX LIMITED
Reel/Frame 050203/0583 →
Continuity (1)
Related Publication 20190388566A1 · Dec 26, 2019